Categories
Uncategorized

Answer Bromodomain Inhibitor

(+)-JQ-1

(+)-JQ1 is definitely a Assume bromodomain inhibitor, with IC50 of 77 nM/33 nM for BRD4(1/2) in cell-free assays, binding for virtually any or all bromodomains of the respective Risk home, although not to bromodomains past the Guess members of your family.

Linked Goods: GSK6853, CPI-637

GSK-3 Inhibitor

CHIR-99021

CHIR-99021 (CT99021) may well be a GSK-3α and GSK-3β inhibitor with IC50 of 10 nM and 6.7 nM, correspondingly.

Important Items: TDZD-8 , SB 216763

MEK Inhibitor

PD98059

PD98059 is actually a non-ATP very competing MEK inhibitor with IC50 of 2 μM inside a cellular-cost-cost-free assay, particularly inhibits MEK-1-mediated activation of MAPK slips level to directly slow down ERK1 or ERK2.

Appropriate Merchandise: GDC-0623 , APS-2-79

AChR Antagonist

Forskolin

Forskolin is really a all-pervasive activator of eukaryotic adenylyl cyclase (AC) in several cellphone sorts, traditionally used to improve levels of outdoor camping in the assessment and study of cellphone physiology.

Relevant Items: Isoprenaline hydrochloride

G9a/GLP Inhibitor

A-366

Productive and critical G9a/GLP histone lysine methyltransferase inhibitor (IC50= 3.3 nM).

Linked Goods: DIM-C-pPhOH , CCT241736

Product Catalog

Substance Collection

45 types of element libraries for high throughput screening and information affirmation.

Investigation Territories

Proteases/Proteasome

Chromatin/Epigenetic

JAK/STAT signaling

Tyrosine Kinase/Adaptors

PI3K/Akt/mTOR Signaling

MAPK Signaling

Apotosis

Ubiquitination

Angiogenesis

Immunology/Soreness

DNA Problems/DNA Resolve

See A lot more…

UsaTel: 781-999-4286 Fax: 857-239-8801

Electronic mail: marketing and advertising@targetmol.com

Include: Collection 260,36 Washington Group WELLESLEY Hillsides MA 02481 US

This which implies was shipped to marketing@tsbiochem.com by sarah.shi@targetmol.com

Collection 260,36 Washington Region WELLESLEY Mountain ranges MA 02481 US

Leave a Reply

Your email address will not be published. Required fields are marked *